Biomarkers of Muscle Anabolism (MK-0000-082)

Clinical trial NCT00812396 · COMPLETED

Trial details

NCT number: NCT00812396
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Muscle Anabolism

Start date: 2007-11-01
Primary completion: 2008-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.